Discontinuation report ERYC DELAYED-RELEASE CAPSULES

Last updated on 2019-10-01 History
Report ID 95138
Drug Identification Number 00607142
Brand name ERYC DELAYED-RELEASE CAPSULES
Common or Proper name Eryc
Company Name PFIZER CANADA ULC
Active Ingredient(s) ERYTHROMYCIN
Strength(s) 250MG
Dosage form(s) CAPSULE (ENTERIC-COATED)
Route of administration ORAL
Packaging size 1 x 100s
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-04-01
Actual discontinuation date
Remaining supply date 2020-04-01
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Eryc 333mg 1x100s presentation remains available
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-10-01 French Compare
v1 2019-10-01 English Compare